BIOMAT Database Logo BIOMAT Database Logo

Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy. 1994

S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
Department of Paediatrics, Wilhelmina Children's Hospital, Utrecht University, The Netherlands.

The ontogeny of serum insulin-like growth factors (IGFs)-I and -II and their binding proteins (IGFBPs) was studied in normal and dwarf Snell mice. IGF-I concentrations in serum of normal mice increased between 4 and 8 weeks of age; dwarf mice had very low serum IGF-I levels. In both normals and dwarfs, serum IGF-II levels were highest soon after birth and dropped steadily thereafter. Western ligand blots of serum IGFBPs with 125I-IGF-II as tracer revealed the expected bands of 41.5, 38.5, 30-32 and 24 kDa. In normal mice the IGFBP-3 doublet was already detectable at 2 weeks of age, and its intensity increased with age. In dwarf mice the IGFBP-3 doublet was hardly detectable. The changes of IGFs and their IGFBPs were studied in sera of dwarf mice after treatment with growth hormone (GH) and/or thyroxine (T4) for 4 weeks. In spite of a comparable growth response obtained using these hormones, serum IGF-I was increased only by GH treatment; a small but significant decrease of serum IGF-II was obtained following GH or T4 treatment. An increase of the IGFBP-3 doublet was only obtained with GH; T4 and GH + T4 had no effect. The rise of IGFBP-3 after GH treatment was accompanied by the formation of the IGFBP 150 kDa complex, as measured by neutral gel chromatography. The size distribution of 125I-IGF-II was restored to normal, while with 125I-IGF-I only a small peak at 150 kDa was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D009924 Organ Culture Techniques A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1) Organ Culture,Culture Technique, Organ,Culture Techniques, Organ,Organ Culture Technique,Organ Cultures
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004392 Dwarfism A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height. Nanism
D005260 Female Females

Related Publications

S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
The Snell-dwarfmouse. I. General growth pattern, before and during growth hormone and thyroxine therapy.
December 1978, Acta endocrinologica,
S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
[Effect of growth hormone and thyroxine on renal development in Snell pituitary dwarf mice].
June 1995, Hinyokika kiyo. Acta urologica Japonica,
S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
Insulin-like growth factors I and II and their binding proteins in rat milk.
January 1991, Pediatric research,
S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: correlation with insulin-like growth factors I and II.
March 1993, Neuroscience,
S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice.
January 1988, Hormone research,
S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
Ontogeny of insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in porcine serum during fetal and postnatal development.
May 1991, Endocrinology,
S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
Insulin-like growth factors and their binding proteins.
July 1990, Acta endocrinologica,
S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
Insulin-like growth factors and their binding proteins.
July 1990, Physiological reviews,
S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
The anabolic actions of growth hormone and thyroxine on protein metabolism in Snell dwarf and normal mice.
October 1988, The Journal of endocrinology,
S C van Buul-Offers, and R J Bloemen, and M G Reijnen-Gresnigt, and H A van Leiden, and C M Hoogerbrugge, and J L Van den Brande
Biosynthetic human growth hormone: effects on growth of Snell dwarf mice.
January 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Copied contents to your clipboard!